• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

RSIP Vision Launches AI-Based, 3D Total Hip Replacement Solution

Share:

December 31, 2019

Highlights on this story:
  • RSIP Vision launches a new AI-based solution that provides a precise automated 3D structure for physicians to better plan surgery.
  • The new AI-based technology will create a precise fit of the new implant to best fit the patients’ body, enabling a better clinical outcome and an easier recovery.

RSIP Vision, an Israeli global provider of artificial intelligence (AI), computer vision, and image processing technology, announced today a new AI-based total hip replacement solution that provides a precise, automated 3D structure of the patients’ hip for physicians to better plan surgery.

A total hip replacement is a surgical procedure where the diseased cartilage and bone of the hip joint is surgically replaced with artificial materials. In the U.S. alone, there are 370,000 hip replacements performed annually and the volumes are growing each year. In most cases, the THA`s (Total Hip Arthroplasty) are performed because of progressive worsening of severe arthritis in the hip joint and in most cases osteoarthritis.

The hip is a complex anatomical region, which has a direct impact on a person’s posture and lower limb movement. Consequently, a hip replacement is an error-prone surgery and the precision level required for the surgery is very high. Even a minor displacement of an implant or inaccurate sizing and shaping of the implants can impact the posture of a patient, causing great pain from simple movements, functional limitations, and even additional surgeries.

How It Works

The new AI-based technology will create a precise fit of the new implant to best fit the patients’ body, enabling a better clinical outcome and an easier recovery. At the heart of the solution is a cutting-edge AI algorithm, that brings new capabilities to the world of Orthopedy.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Instead of relying on a surgeons’ personal experience, this new solution allows complex segmentation and landmark detection of the patient’s body structure, making the surgical planning much simpler, faster and accurate.

Why It Matters

“THA became very common procedure nowadays, it is performed daily in most medical centers. Recovery and rehabilitation depend on planning the procedure and selecting the perfect implant, which is tailor made for each unique patient. This is time consuming and at the same time crucial for the success of the operation,” says Dr. Rabeeh Fares, Radiologist; Department of Diagnostic Radiology, Sourasky Medical Center, Tel Aviv. “From our perspective, a fully automated algorithm for segmentation of a diseased joint has become mandatory in our daily practice as it is far more accurate and time saving in comparison with a manual method.”

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Westfall Technik Acquires Three Businesses In Their Seventh Transaction In Seven MonthsWestfall Technik Acquires Three Businesses In Their Seventh Transaction In Seven Months
  • Caption Health Receives FDA 510(k) Clearance for Innovation in Point-of-Care Ejection Fraction EvaluationCaption Health Receives FDA 510(k) Clearance for Innovation in Point-of-Care Ejection Fraction Evaluation
  • Orphazyme A/S Under In-Court-Restructuring to Sell Substantially all of Its Assets and Business Activities to KemPharm, Inc.Orphazyme A/S Under In-Court-Restructuring to Sell Substantially all of Its Assets and Business Activities to KemPharm, Inc.
  • 3B Scientific Acquires iSimulate3B Scientific Acquires iSimulate
  • Plenty of Investigations have found Consumer Health Apps to have False Content, Bad Functionality, Poor DesignPlenty of Investigations have found Consumer Health Apps to have False Content, Bad Functionality, Poor Design
  • Merck Completes Acquisition of Pandion TherapeuticsMerck Completes Acquisition of Pandion Therapeutics
  • AlleyCorp Launches $100M Healthcare Venture Fund for NYC Early-Stage Digital Health StartupsAlleyCorp Launches $100M Healthcare Venture Fund for NYC Early-Stage Digital Health Startups
  • SubjectWell, Human API Partner to Provide Free Patient Medical Record RetrievalSubjectWell, Human API Partner to Provide Free Patient Medical Record Retrieval

Trending This Week

  • Immuno-Oncology Pipeline Cuts Explained
  • Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
  • USFDA Accepts Glenmark’s Application to Initiate a Human Trial of Molecules for Advanced Solid Tumors and Lymphomas
  • Concentra’s Buy Offer May Jeopardize Jounce’s Merger with Redx
  • Pfizer Acquires Seagen For $43B To Tackle Cancer
  • Janssen’s Novel Dengue Antiviral Demonstrates ‘strong Protection’ in Pre-Clinical Data

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications